Vaccine ENGERIX (Adult) – (1,050) at Dr. Essa Lab

Vaccine ENGERIX (Adult) – (1,050) at Dr. Essa Lab

The Vaccine ENGERIX (Adult) – (1,050) at Dr. Essa Lab represents a vital preventive healthcare service designed to provide active, long-term immunization against the Hepatitis B virus (HBV). Hepatitis B is a highly contagious, blood-borne, and sexually transmitted viral pathogen that primarily targets the liver. Left unchecked, acute Hepatitis B can progress to chronic liver disease, liver cirrhosis, hepatic failure, and hepatocellular carcinoma (primary liver cancer). The Engerix-B vaccine is a non-infectious recombinant DNA vaccine containing purified hepatitis B surface antigen (HBsAg). It is produced using genetically engineered yeast (Saccharomyces cerevisiae) cells that carry the gene coding for the surface antigen. Because the vaccine contains only the purified antigen and no live viral DNA, it cannot cause Hepatitis B infection, making it exceptionally safe while maintaining a high level of immunogenicity.

Dr. Essa Lab, a pioneer in diagnostic and preventive medicine in Pakistan, particularly across Karachi, offers this immunization service under strict clinical protocols. Vaccines are highly temperature-sensitive biological products that require precise storage conditions to maintain their potency. Dr. Essa Lab strictly adheres to international cold chain management standards, ensuring the vaccine is stored and transported within the recommended temperature range of 2 to 8 degrees Celsius. This meticulous care guarantees that every dose administered is highly effective. Active immunization is the most successful clinical strategy to eliminate the transmission of Hepatitis B, and Dr. Essa Lab provides a sterile, professional, and patient-centric environment for individuals seeking to protect themselves and their families from this chronic health threat.

Clinical Procedure: What to Expect

Patient Preparation

• No Fasting Required: There are no dietary restrictions or fasting requirements before receiving the Vaccine ENGERIX (Adult) – (1,050) at Dr. Essa Lab. Patients can eat and drink normally.
• Allergy Screening: Inform the healthcare provider of any known allergies, especially severe hypersensitivity to yeast or any other component of the vaccine.
• Medical History Disclosure: Disclose your complete medical history, including any current acute illnesses, high fever, or moderate-to-severe infections. Mild illnesses, such as a common cold, generally do not require delaying vaccination.
• Bleeding Disorders: Notify the clinician if you have a bleeding disorder, such as hemophilia, or if you are taking blood thinners (anticoagulants), as this may require specific injection techniques to prevent localized hematoma.
• Previous Vaccine Reactions: Provide details about any previous vaccinations, particularly if you experienced an adverse reaction to a prior dose of a Hepatitis B vaccine.
• Pregnancy and Lactation: If you are pregnant, planning to become pregnant, or breastfeeding, discuss the clinical benefits and risks with your physician before proceeding with the immunization.

During the Procedure

• Patient Verification: The clinical staff at Dr. Essa Lab will verify your identity, medical history, and the specific vaccine details to ensure complete safety.
• Injection Site Preparation: The patient is comfortably seated, and the injection site, typically the deltoid muscle of the upper arm, is thoroughly cleansed with an antiseptic alcohol swab and allowed to air dry.
• Intramuscular Administration: The Vaccine ENGERIX (Adult) – (1,050) is administered via intramuscular (IM) injection. The deltoid muscle is the preferred site in adults because administration in the gluteal muscle is associated with lower immunogenicity and a suboptimal immune response due to fat tissue absorption.
• Sterile Technique: The clinician uses a sterile, single-use syringe to deliver the 1.0 mL (20 micrograms) dose of the vaccine.
• Sensation and Duration: The injection itself takes only a few seconds, during which the patient may feel a mild, brief pinching sensation or localized pressure.
• Post-Injection Care: After the injection, gentle pressure is applied to the site with a sterile cotton ball or gauze, and a small adhesive bandage may be applied.
• Observation Period: Patients are advised to remain in the waiting area for approximately 15 to 20 minutes post-vaccination to monitor for any immediate, though rare, allergic reactions or vasovagal syncope (fainting).

When is a Vaccine ENGERIX (Adult) – (1,050) Performed?

Prevention of Hepatitis B Virus Infection

Active immunization with Vaccine ENGERIX (Adult) – (1,050) is indicated for all susceptible adults who wish to protect themselves against Hepatitis B virus infection. Because Hepatitis B is highly contagious and can survive on environmental surfaces for up to seven days, vaccination serves as the primary shield against accidental exposure. It stimulates the body’s natural immune system to produce specific antibodies (anti-HBs) that neutralize the virus upon contact, preventing both acute infection and the development of a lifelong chronic carrier state.

Occupational Exposure and Healthcare Workers

Healthcare professionals, including physicians, nurses, laboratory technicians, dentists, and emergency medical personnel, face a heightened risk of exposure to blood-borne pathogens. Accidental needle-stick injuries, splashes of bodily fluids, and handling of clinical specimens can transmit Hepatitis B. Dr. Essa Lab provides this vaccine to ensure that frontline workers establish robust immunity, minimizing occupational health hazards and maintaining a safe clinical environment.

Travelers to High-Endemic Regions

Individuals traveling to regions with moderate-to-high prevalence rates of Hepatitis B, such as parts of Sub-Saharan Africa, East Asia, and the Amazon basin, are strongly advised to receive the vaccine. Exposure risks during travel can arise from medical emergencies requiring blood transfusions, dental procedures, or accidental injuries. Completing the vaccine series before departure ensures long-term protection during international travel.

Patients with Chronic Liver Disease or Kidney Failure

Patients diagnosed with chronic liver conditions, such as Hepatitis C, non-alcoholic fatty liver disease (NAFLD), or cirrhosis, are highly vulnerable to severe complications if they contract Hepatitis B. Additionally, patients undergoing long-term hemodialysis are at an increased risk of blood-borne exposure. Administering the vaccine helps protect these compromised organ systems from secondary viral insults that could accelerate liver failure.

High-Risk Lifestyle and Household Contacts

Vaccination is critical for individuals living in close contact with an HBsAg-positive person, as the virus can be transmitted through shared personal items like razors or toothbrushes. It is also highly recommended for individuals with multiple sexual partners, those seeking treatment for sexually transmitted infections, and intravenous drug users, as these factors significantly elevate the probability of viral transmission.

What Does a Vaccine ENGERIX (Adult) – (1,050) Prevent and Protect Against?

• Prevention of acute Hepatitis B infection and its associated debilitating symptoms.
• Prevention of chronic Hepatitis B carrier state, which can lead to lifelong viral replication.
• Stimulation of the immune system to produce protective anti-HBs antibodies.
• Prevention of progressive liver damage, including hepatic inflammation and necrosis.
• Significant reduction in the risk of developing liver cirrhosis (scarring of liver tissue).
• Prevention of hepatocellular carcinoma (primary liver cancer) associated with chronic HBV.
• Protection against fulminant hepatitis, a rare but life-threatening acute liver failure.
• Prevention of co-infection with Hepatitis D (delta virus), which requires HBV to replicate.
• Reduction of horizontal transmission of the virus to family members and household contacts.
• Prevention of vertical transmission from mother to child during future pregnancies.
• Protection of patients undergoing frequent blood transfusions or receiving blood products.
• Protection of individuals undergoing hemodialysis or peritoneal dialysis.
• Prevention of HBV-associated extrahepatic complications, such as polyarteritis nodosa.
• Prevention of membranous glomerulonephritis, a kidney disorder linked to chronic HBV.
• Protection for diabetic patients who may share blood glucose monitoring equipment.
• Reduction of the overall community burden of Hepatitis B through herd immunity.
• Prevention of liver transplantation requirements caused by end-stage Hepatitis B liver disease.
• Protection against accidental needle-stick injuries in clinical and laboratory settings.
• Establishment of long-term immunological memory lasting for decades.
• Prevention of portal hypertension and its complications, such as esophageal varices.
• Prevention of ascites (fluid accumulation in the abdomen) resulting from liver failure.
• Prevention of hepatic encephalopathy, a neuropsychiatric syndrome caused by liver dysfunction.
• Protection for travelers visiting areas with poor sanitation or high HBV endemicity.
• Prevention of chronic fatigue and systemic malaise associated with chronic liver infections.
• Ensuring peace of mind for individuals working in high-risk public safety or military roles.

Turnaround Time and Report Access at Dr. Essa Lab

Upon receiving the Vaccine ENGERIX (Adult) – (1,050) at Dr. Essa Lab, patients are immediately provided with a physical vaccination card detailing the vaccine brand, batch number, date of administration, and the scheduled dates for subsequent doses (typically following a 0, 1, and 6-month schedule). Dr. Essa Lab also maintains digital records of all patient procedures. Patients can access their immunization history and receipt details online through the official Dr. Essa Lab web portal or mobile application. This digital access ensures that patients can easily retrieve their vaccination records for occupational, academic, or travel requirements at any time, eliminating the risk of lost physical documentation.

Vaccine ENGERIX (Adult) – (1,050) Findings Overview

Parameter Evaluated	Normal / Expected Response	Possible Abnormal / Suboptimal Response
Anti-HBs Antibody Titer	Titer >= 10 mIU/mL (Indicates protective immunity)	Titer < 10 mIU/mL (Non-responder; may require booster or repeat series)
Injection Site Reaction	No reaction or mild, transient soreness/redness	Severe pain, persistent swelling, or sterile abscess (rare)
Systemic Temperature	Normal body temperature (afebrile)	Low-grade fever (transient) or high fever (unrelated infection)
Immune System Activation	Successful production of specific neutralizing antibodies	Impaired immune response (immunocompromised states)
Vaccination Schedule Adherence	Completion of 3-dose series (0, 1, and 6 months)	Incomplete series (delayed or missed doses, reducing efficacy)
Hypersensitivity Response	No allergic reaction	Immediate hypersensitivity or anaphylaxis (extremely rare)
Liver Function Post-Exposure	Normal liver enzyme levels (ALT, AST)	Elevated liver enzymes if exposed prior to achieving immunity
Immunological Memory	Long-term T-cell and B-cell memory established	Rapid decline in antibody levels without memory (rare)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for Vaccine ENGERIX (Adult) – (1,050)?

• Experienced healthcare professionals who ensure sterile and precise vaccine administration.
• Strict cold chain maintenance to preserve the potency and efficacy of Vaccine ENGERIX (Adult) – (1,050).
• Patient-focused care with a dedicated post-vaccination observation period for safety.
• Convenient locations across Karachi and other major cities, making immunization highly accessible.
• Comprehensive digital record-keeping, allowing easy access to vaccination history via portal and app.
• Adherence to international healthcare standards and sterile clinical protocols.
• Affordable and transparent pricing for essential preventive healthcare services.
• A trusted diagnostic legacy since 1987, recognized for accuracy and clinical excellence.